Matches in Wikidata for { <http://www.wikidata.org/entity/Q91745069> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91745069 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91745069 description "scientific article published on 03 July 2019" @default.
- Q91745069 description "wetenschappelijk artikel" @default.
- Q91745069 description "наукова стаття, опублікована 3 липня 2019" @default.
- Q91745069 name "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 name "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 type Item @default.
- Q91745069 label "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 label "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 prefLabel "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 prefLabel "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 P1433 Q91745069-6701DE90-7FA0-4381-A0A4-B024EBDCB212 @default.
- Q91745069 P1476 Q91745069-87CD850E-C9FE-42EF-A17E-4874B66A5823 @default.
- Q91745069 P2093 Q91745069-5804AE07-7F89-4343-8A60-22228D03A1B9 @default.
- Q91745069 P2093 Q91745069-983E74C1-13C7-4692-A230-BBA802592706 @default.
- Q91745069 P2093 Q91745069-A22D06EF-184F-4635-9F2E-B41DCA3D5AFB @default.
- Q91745069 P304 Q91745069-ED462808-632B-405C-BE39-D3EAB1F164CD @default.
- Q91745069 P31 Q91745069-8E4C6B3E-431C-49B9-8050-A99BC5C25B94 @default.
- Q91745069 P356 Q91745069-CDE7EF80-038E-41A8-A9FE-8147301EFD15 @default.
- Q91745069 P478 Q91745069-3E6571CE-EF07-4AE5-AD0D-712CA03E4564 @default.
- Q91745069 P50 Q91745069-2AA7B48B-F812-4E3D-94FE-8D8EDAC7ACB3 @default.
- Q91745069 P50 Q91745069-7DE67110-33A7-4634-AA31-0BA51B41509A @default.
- Q91745069 P50 Q91745069-9C07F2CA-8E7D-4C03-BB6B-9310230F58BA @default.
- Q91745069 P50 Q91745069-A8664104-41E3-4432-8AC1-C31AD24DF43B @default.
- Q91745069 P577 Q91745069-C268B562-571A-4607-8F88-E7E0C24AE7F5 @default.
- Q91745069 P698 Q91745069-EE2C60FA-7FB4-4D07-8DA0-ACBAEECACFDE @default.
- Q91745069 P921 Q91745069-42E6203B-DCB4-412F-8DBF-03FAB342101E @default.
- Q91745069 P356 J.EJMECH.2019.07.001 @default.
- Q91745069 P698 31288149 @default.
- Q91745069 P1433 Q3008624 @default.
- Q91745069 P1476 "A new series of bicalutamide, enzalutamide and enobosarm derivatives carrying pentafluorosulfanyl (SF5) and pentafluoroethyl (C2F5) substituents: Improved antiproliferative agents against prostate cancer" @default.
- Q91745069 P2093 "Andrew D Westwell" @default.
- Q91745069 P2093 "Christopher McGuigan" @default.
- Q91745069 P2093 "Sahar Khandil" @default.
- Q91745069 P304 "1-14" @default.
- Q91745069 P31 Q13442814 @default.
- Q91745069 P356 "10.1016/J.EJMECH.2019.07.001" @default.
- Q91745069 P478 "180" @default.
- Q91745069 P50 Q39184463 @default.
- Q91745069 P50 Q42293878 @default.
- Q91745069 P50 Q42705803 @default.
- Q91745069 P50 Q55192709 @default.
- Q91745069 P577 "2019-07-03T00:00:00Z" @default.
- Q91745069 P698 "31288149" @default.
- Q91745069 P921 Q1988832 @default.